866-997-4948(US-Canada Toll Free)

United States Rotavirus Vaccine Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 95 Pages

Notes:
Sales, means the sales volume of Rotavirus Vaccine
Revenue, means the sales value of Rotavirus Vaccine

This report studies sales (consumption) of Rotavirus Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Astellas Pharma
CSL Limited
Emergent BioSolutions
GlaxoSmithKline
Johnson&Johnson
MedImmune
Merck
...

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Rotavirus Vaccine in each application, can be divided into
Application 1
Application 2

Table of Contents

United States Rotavirus Vaccine Market Report 2017
1 Rotavirus Vaccine Overview
1.1 Product Overview and Scope of Rotavirus Vaccine
1.2 Classification of Rotavirus Vaccine
1.2.1 Type I
1.2.2 Type II
1.3 Application of Rotavirus Vaccine
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Rotavirus Vaccine (2012-2022)
1.4.1 United States Rotavirus Vaccine Sales and Growth Rate (2012-2022)
1.4.2 United States Rotavirus Vaccine Revenue and Growth Rate (2012-2022)

2 United States Rotavirus Vaccine Competition by Manufacturers
2.1 United States Rotavirus Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Rotavirus Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Rotavirus Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Rotavirus Vaccine Market Competitive Situation and Trends
2.4.1 Rotavirus Vaccine Market Concentration Rate
2.4.2 Rotavirus Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Rotavirus Vaccine Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Rotavirus Vaccine Sales and Market Share by States (2012-2017)
3.2 United States Rotavirus Vaccine Revenue and Market Share by States (2012-2017)
3.3 United States Rotavirus Vaccine Price by States (2012-2017)

4 United States Rotavirus Vaccine Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Rotavirus Vaccine Sales and Market Share by Type (2012-2017)
4.2 United States Rotavirus Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Rotavirus Vaccine Price by Type (2012-2017)
4.4 United States Rotavirus Vaccine Sales Growth Rate by Type (2012-2017)

5 United States Rotavirus Vaccine Sales (Volume) by Application (2012-2017)
5.1 United States Rotavirus Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Rotavirus Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Rotavirus Vaccine Manufacturers Profiles/Analysis
6.1 Astellas Pharma
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Rotavirus Vaccine Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Astellas Pharma Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 CSL Limited
6.2.2 Rotavirus Vaccine Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 CSL Limited Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Emergent BioSolutions
6.3.2 Rotavirus Vaccine Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Emergent BioSolutions Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
6.4.2 Rotavirus Vaccine Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 GlaxoSmithKline Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Johnson&Johnson
6.5.2 Rotavirus Vaccine Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Johnson&Johnson Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 MedImmune
6.6.2 Rotavirus Vaccine Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 MedImmune Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Merck
6.7.2 Rotavirus Vaccine Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Merck Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
...

7 Rotavirus Vaccine Manufacturing Cost Analysis
7.1 Rotavirus Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Rotavirus Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Rotavirus Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Rotavirus Vaccine Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Rotavirus Vaccine Market Forecast (2017-2022)
11.1 United States Rotavirus Vaccine Sales, Revenue Forecast (2017-2022)
11.2 United States Rotavirus Vaccine Sales Forecast by Type (2017-2022)
11.3 United States Rotavirus Vaccine Sales Forecast by Application (2017-2022)
11.4 Rotavirus Vaccine Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Rotavirus Vaccine
Table Classification of Rotavirus Vaccine
Figure United States Sales Market Share of Rotavirus Vaccine by Type in 2015
Table Application of Rotavirus Vaccine
Figure United States Sales Market Share of Rotavirus Vaccine by Application in 2015
Figure United States Rotavirus Vaccine Sales and Growth Rate (2012-2022)
Figure United States Rotavirus Vaccine Revenue and Growth Rate (2012-2022)
Table United States Rotavirus Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Rotavirus Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Rotavirus Vaccine Sales Share by Manufacturers
Figure 2016 Rotavirus Vaccine Sales Share by Manufacturers
Table United States Rotavirus Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Rotavirus Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Rotavirus Vaccine Revenue Share by Manufacturers
Table 2016 United States Rotavirus Vaccine Revenue Share by Manufacturers
Table United States Market Rotavirus Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Rotavirus Vaccine Average Price of Key Manufacturers in 2015
Figure Rotavirus Vaccine Market Share of Top 3 Manufacturers
Figure Rotavirus Vaccine Market Share of Top 5 Manufacturers
Table United States Rotavirus Vaccine Sales by States (2012-2017)
Table United States Rotavirus Vaccine Sales Share by States (2012-2017)
Figure United States Rotavirus Vaccine Sales Market Share by States in 2015
Table United States Rotavirus Vaccine Revenue and Market Share by States (2012-2017)
Table United States Rotavirus Vaccine Revenue Share by States (2012-2017)
Figure Revenue Market Share of Rotavirus Vaccine by States (2012-2017)
Table United States Rotavirus Vaccine Price by States (2012-2017)
Table United States Rotavirus Vaccine Sales by Type (2012-2017)
Table United States Rotavirus Vaccine Sales Share by Type (2012-2017)
Figure United States Rotavirus Vaccine Sales Market Share by Type in 2015
Table United States Rotavirus Vaccine Revenue and Market Share by Type (2012-2017)
Table United States Rotavirus Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Rotavirus Vaccine by Type (2012-2017)
Table United States Rotavirus Vaccine Price by Type (2012-2017)
Figure United States Rotavirus Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Rotavirus Vaccine Sales by Application (2012-2017)
Table United States Rotavirus Vaccine Sales Market Share by Application (2012-2017)
Figure United States Rotavirus Vaccine Sales Market Share by Application in 2015
Table United States Rotavirus Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Rotavirus Vaccine Sales Growth Rate by Application (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Pharma Rotavirus Vaccine Sales Market Share (2012-2017)
Table CSL Limited Basic Information List
Table CSL Limited Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table CSL Limited Rotavirus Vaccine Sales Market Share (2012-2017)
Table Emergent BioSolutions Basic Information List
Table Emergent BioSolutions Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Emergent BioSolutions Rotavirus Vaccine Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Rotavirus Vaccine Sales Market Share (2012-2017)
Table Johnson&Johnson Basic Information List
Table Johnson&Johnson Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Johnson&Johnson Rotavirus Vaccine Sales Market Share (2012-2017)
Table MedImmune Basic Information List
Table MedImmune Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table MedImmune Rotavirus Vaccine Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Rotavirus Vaccine Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rotavirus Vaccine
Figure Manufacturing Process Analysis of Rotavirus Vaccine
Figure Rotavirus Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Rotavirus Vaccine Major Manufacturers in 2015
Table Major Buyers of Rotavirus Vaccine
Table Distributors/Traders List
Figure United States Rotavirus Vaccine Production and Growth Rate Forecast (2017-2022)
Figure United States Rotavirus Vaccine Revenue and Growth Rate Forecast (2017-2022)
Table United States Rotavirus Vaccine Production Forecast by Type (2017-2022)
Table United States Rotavirus Vaccine Consumption Forecast by Application (2017-2022)
Table United States Rotavirus Vaccine Sales Forecast by States (2017-2022)
Table United States Rotavirus Vaccine Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *